Scopus BioPharma Inc. (SCPS) Prices 500K Share IPO at $5.50/Sh

Scopus BioPharma Inc. (NASDAQ: SCPS) today announced the pricing of its initial public offering.

The company's common stock is set to begin trading Wednesday, December 16, 2020 on the Nasdaq Global Market under the ticker symbol "SCPS".

The company is offering 500,000 shares of common stock at a public offering price of $5.50 per share.

The Benchmark Company, LLC acted as Sole Bookrunning Manager and Joseph Gunnar & Co., LLC acted as Co-Manager for the offering.

Greenberg Traurig, LLP is acting as counsel to the company. Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. is acting as counsel to the underwriters.

An offering statement relating to the shares of common stock was filed with the U.S. Securities and Exchange Commission and became qualified on December 14, 2020.

You May Also Be Interested In

• Karman Line Acquisition closes $200M IPO on Nasdaq
• Cosmos Health signs Saudi distribution deal for supplement line
• Singularity Future Technology prices $5M direct offering at $3.20 per share